RIST4721 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 266 | 家族性地中海熱 | 1 |
266. 家族性地中海熱
臨床試験数 : 28 / 薬物数 : 22 - (DrugBank : 5) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 59
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05448391 (ClinicalTrials.gov) | September 13, 2022 | 1/7/2022 | A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) | An Open-label, Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of RIST4721 in Subjects With Familial Mediterranean Fever | Familial Mediterranean Fever | Drug: RIST4721 | Aristea Therapeutics, Inc. | NULL | Withdrawn | 18 Years | 74 Years | All | 0 | Phase 2 | Israel;Turkey |